We have synthesized an 18-amino acid pep- The tat protein from human immunodeficiency virus is a viral trans-activator (1) and is an attractive target for drug design because the protein is essential for viral replication (2, 3). Tat is 86 amino acids long and contains a highly basic region (two lysines and six arginines within 9 residues) and a cysteinerich region (seven cysteines within 16 residues) ( Fig. 1 ) (4, 5).
The tat protein from human immunodeficiency virus is a viral trans-activator (1) and is an attractive target for drug design because the protein is essential for viral replication (2, 3) . Tat is 86 amino acids long and contains a highly basic region (two lysines and six arginines within 9 residues) and a cysteinerich region (seven cysteines within 16 residues) ( Fig. 1) (4, 5) . We have recently shown that purified tat can form metallinked dimers (6) . This dimer structure contains four metal ions, and it appears that two or more of the metal ions bridge the cysteine-rich regions from each monomer. tat-Cd2+ dimers are very stable (the protein dimerizes at low pH or in the presence of NaDodSO4) and dimers can also be formed with Zn2+. From proteolytic digestion studies and circular dichroism spectra, we concluded that the structural effects of metal binding were localized primarily, if not exclusively, to the cysteine-rich region.
Although there is no direct evidence yet for the biological role of the metal-linked dimers, the reducing environment and relatively high metal concentrations in eukaryotic cells may allow tat to form similar dimers in vivo. If dimerization is required for trans-activation, one might inactivate tat by forming heterodimers with truncated or inactive subunits. We imagine these mutant subunits would be trans-dominant.
[Many DNA-binding proteins can be inactivated by adding subunits that contain a normal dimer contact site but a defective DNA-binding site (7) .] To explore this possibility and to simplify structural studies of the dimer interface, we have synthesized an 18-amino acid peptide containingjust the cysteine-rich region of tat (residues 21-38; Fig. 1 metal ions bind per peptide molecule. These spectra are virtually identical to those seen with intact tat (6) . Difference spectra were used to monitor the effect of pH on the peptideCd2`complex (Fig. 2b) (6) .
Metal-Linked Dimerization of tat2l_18. Does tat21.38, like the intact protein, form metal-linked dimers? Because of the small size of the peptide and problems resulting from oxidation, we were unable to readily monitor dimerization on native or NaDodSO4 gels. However, the low molecular weight of the peptide made it possible to use plasma desorption mass spectrometry to monitor dimerization. Two broad peaks are observed for the tat2l_38-Cd2+ complex (Fig. 3) , and these correspond roughly to the molecular weights of the monomer and dimer. Each peak exhibits some "fine structure" that indicates the stoichiometry of the peptide-metal complexes. Within (Fig. 5) . In a previous study, we found that the CD spectrum of intact tat changed very little as the metals bound, leading us to suggest that metals do not mediate a global folding transition for tat (6) . Apparently, the structural changes are concentrated in the cysteine-rich region since we see greater changes in the spectrum (on a wt/wt basis) as metals bind to the peptide.
Inhibition of tat Dimerization by tat21-38. Can tat21.38 "inhibit" tat dimer formation by forming metal-linked heterodimers? Since tat-Cd2 + dimers are stable during NaDod-S04 gel electrophoresis (6) , we used this method to look for heterodimers (Fig. 6) use liposomes to deliver peptides or their genes to specific cells (12) . It might also be possible to make hydrophobic variants of this peptide, which could be more easily taken up by cells. Alternatively, one might design chelators or other organic compounds that would bind to tat monomers and inhibit normal metal-linked dimerization.
